
Significant investments in R&D, fast-rising healthcare needs, expansion of drug pipelines, and a growing demand for personalized drugs bolster the biotech industry.
Given this backdrop, investors could consider buying biotech stocks such as Esperion Therapeutics, Inc. (ESPR), Corcept Therapeutics Incorporated (CORT), and Shionogi & Co., Ltd. (SGIOY).